The Pannucci Research Lab focuses on venous thromboembolism, which are life or limb-threatening blood clots that occur in surgical patients. The group examines the role of care individualization for VTE using a precision medicine approach, which treats the patient as an individual instead of the larger aggregate.
The group also examines the role of patient-centric VTE risk stratification to identify patients who will and will not benefit from post-operative blood thinners, as well as the identification of patient-specific factors that predict how patients will metabolize post-operative blood thinners. Dr. Pannucci’s work currently receives funding from the Agency for Healthcare and Research Quality and the Association for Academic Surgeons.
